FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108808854> ?p ?o ?g. }

• W2108808854 endingPage "2520" @default.
• W2108808854 startingPage "2513" @default.
• W2108808854 abstract "Colon cancer is the fourth and third most common cancer, respectively in men and women worldwide and its incidence is on the increase. Stress response has been associated with the incidence and development of cancer. The catecholamines (CA), adrenaline (AD) and noradrenaline (NA), are crucial mediators of stress response, exerting their effects through interaction with α- and β-adrenergic receptors (AR). Colon cancer cells express β-AR, and their activation has been implicated in carcinogenesis and tumor progression. Interest concerning the efficacy of β-AR blockers as possible additions to cancer treatment has increased. The aim of this study was to investigate the effect of several AR agonists and β-blockers following cell proliferation of HT-29 cells, a human colon adenocarcinoma cell line. For this purpose, HT-29 cells were incubated in the absence (control) or in the presence of the AR-agonists, AD, NA and isoprenaline (ISO) (0.1-100 µM) for 12 or 24 h. The tested AR agonists revealed proliferative effects on HT-29 cells. In order to study the effect of several β-blockers following proliferation induced by AR activation, the cells were treated with propranolol (PRO; 50 µM), carvedilol (CAR; 5 µM), atenolol (ATE; 50 µM), or ICI 118,551 (ICI; 5 µM) for 45 min prior, and simultaneously, to incubation with each of the AR agonists, AD and ISO, both at 1 and 10 µM. The results suggested that adrenergic activation plays an important role in colon cancer cell proliferation, most probably through β-AR. The β-blockers under study were able to reverse the proliferation induced by AD and ISO, and some of these blockers significantly decreased the proliferation of HT-29 cells. The elucidation of the intracellular pathways involved in CA-induced proliferation of colon cancer cells, and in the reversion of this effect by β-blockers, may contribute to identifying promising strategies in cancer treatment." @default.
• W2108808854 created "2016-06-24" @default.
• W2108808854 creator A5001085477 @default.
• W2108808854 creator A5002735203 @default.
• W2108808854 creator A5035970867 @default.
• W2108808854 creator A5053524941 @default.
• W2108808854 creator A5063959460 @default.
• W2108808854 creator A5083640539 @default.
• W2108808854 date "2015-03-23" @default.
• W2108808854 modified "2023-10-14" @default.
• W2108808854 title "Antiproliferative effects of β-blockers on human colorectal cancer cells" @default.
• W2108808854 cites W1503765703 @default.
• W2108808854 cites W1654896704 @default.
• W2108808854 cites W1963833383 @default.
• W2108808854 cites W1986400500 @default.
• W2108808854 cites W1987158425 @default.
• W2108808854 cites W1991621680 @default.
• W2108808854 cites W1993717649 @default.
• W2108808854 cites W2051294130 @default.
• W2108808854 cites W2051961864 @default.
• W2108808854 cites W2062289724 @default.
• W2108808854 cites W2078613870 @default.
• W2108808854 cites W2102717686 @default.
• W2108808854 cites W2106787323 @default.
• W2108808854 cites W2121185174 @default.
• W2108808854 cites W2121701522 @default.
• W2108808854 cites W2123207674 @default.
• W2108808854 cites W2127318107 @default.
• W2108808854 cites W2131832357 @default.
• W2108808854 cites W2141382054 @default.
• W2108808854 cites W2142094421 @default.
• W2108808854 cites W2147196684 @default.
• W2108808854 cites W2147891610 @default.
• W2108808854 cites W2151356556 @default.
• W2108808854 cites W2155547273 @default.
• W2108808854 cites W2162062703 @default.
• W2108808854 doi "https://doi.org/10.3892/or.2015.3874" @default.
• W2108808854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25812650" @default.
• W2108808854 hasPublicationYear "2015" @default.
• W2108808854 type Work @default.
• W2108808854 sameAs 2108808854 @default.
• W2108808854 citedByCount "57" @default.
• W2108808854 countsByYear W21088088542016 @default.
• W2108808854 countsByYear W21088088542017 @default.
• W2108808854 countsByYear W21088088542018 @default.
• W2108808854 countsByYear W21088088542019 @default.
• W2108808854 countsByYear W21088088542020 @default.
• W2108808854 countsByYear W21088088542021 @default.
• W2108808854 countsByYear W21088088542022 @default.
• W2108808854 countsByYear W21088088542023 @default.
• W2108808854 crossrefType "journal-article" @default.
• W2108808854 hasAuthorship W2108808854A5001085477 @default.
• W2108808854 hasAuthorship W2108808854A5002735203 @default.
• W2108808854 hasAuthorship W2108808854A5035970867 @default.
• W2108808854 hasAuthorship W2108808854A5053524941 @default.
• W2108808854 hasAuthorship W2108808854A5063959460 @default.
• W2108808854 hasAuthorship W2108808854A5083640539 @default.
• W2108808854 hasBestOaLocation W21088088541 @default.
• W2108808854 hasConcept C121608353 @default.
• W2108808854 hasConcept C126322002 @default.
• W2108808854 hasConcept C134018914 @default.
• W2108808854 hasConcept C170493617 @default.
• W2108808854 hasConcept C185592680 @default.
• W2108808854 hasConcept C2776525901 @default.
• W2108808854 hasConcept C2778151854 @default.
• W2108808854 hasConcept C2781018059 @default.
• W2108808854 hasConcept C29537977 @default.
• W2108808854 hasConcept C502942594 @default.
• W2108808854 hasConcept C526805850 @default.
• W2108808854 hasConcept C55493867 @default.
• W2108808854 hasConcept C555283112 @default.
• W2108808854 hasConcept C62112901 @default.
• W2108808854 hasConcept C71924100 @default.
• W2108808854 hasConcept C84393581 @default.
• W2108808854 hasConcept C96232424 @default.
• W2108808854 hasConcept C98274493 @default.
• W2108808854 hasConceptScore W2108808854C121608353 @default.
• W2108808854 hasConceptScore W2108808854C126322002 @default.
• W2108808854 hasConceptScore W2108808854C134018914 @default.
• W2108808854 hasConceptScore W2108808854C170493617 @default.
• W2108808854 hasConceptScore W2108808854C185592680 @default.
• W2108808854 hasConceptScore W2108808854C2776525901 @default.
• W2108808854 hasConceptScore W2108808854C2778151854 @default.
• W2108808854 hasConceptScore W2108808854C2781018059 @default.
• W2108808854 hasConceptScore W2108808854C29537977 @default.
• W2108808854 hasConceptScore W2108808854C502942594 @default.
• W2108808854 hasConceptScore W2108808854C526805850 @default.
• W2108808854 hasConceptScore W2108808854C55493867 @default.
• W2108808854 hasConceptScore W2108808854C555283112 @default.
• W2108808854 hasConceptScore W2108808854C62112901 @default.
• W2108808854 hasConceptScore W2108808854C71924100 @default.
• W2108808854 hasConceptScore W2108808854C84393581 @default.
• W2108808854 hasConceptScore W2108808854C96232424 @default.
• W2108808854 hasConceptScore W2108808854C98274493 @default.
• W2108808854 hasIssue "5" @default.
• W2108808854 hasLocation W21088088541 @default.
• W2108808854 hasLocation W21088088542 @default.
• W2108808854 hasOpenAccess W2108808854 @default.

• next